The current global obesity epidemic is increasing, leading to an increase in the incidence and prevalence of T2DM by reducing insulin sensitivity in the adipose tissue, liver and skeletal muscle and subsequently impairing beta-cell function, which poses a serious challenge to the healthcare system (65,66). Here, INS is linked to type 2 diabetes mellitus.